alexa Multiple Sclerosis Medication Open Access Articles|omicsgroup|Journal Of Multiple Sclerosis

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Multiple Sclerosis Medication Open Access Articles

Medications used to treat multiple sclerosis include modifying therapies to manage the symptoms and heal the exacerbations. Multiple sclerosis medications reduce and help to manage the common symptoms including bowel dysfunction, depression, sexual problems, spasticity, tremors etc. The common medications used involves methylprednisolone, prednisone etc. But Corticosteroids are not considered as an effective medication to benefit the disease. Some of the effective medications used are glatiramer acetate, fingolimod, peginterferon, beta-1ainterferon, beta-1 adi methyl fumarate, natalizumab etc. Open access to the scientific literature means the removal of barriers (including price barriers) from accessing scholarly work. There are two parallel “roads” towards open access: Open Access articles and self-archiving. Open Access articles are immediately, freely available on their Web site, a model mostly funded by charges paid by the author (usually through a research grant). The alternative for a researcher is “self-archiving” (i.e., to publish in a traditional journal, where only subscribers have immediate access, but to make the article available on their personal and/or institutional Web sites (including so-called repositories or archives)), which is a practice allowed by many scholarly journals.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on September, 2014